Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)

OBJECTIVES: During 2022, Omicron became the dominant SARS-CoV-2 variant in Europe. This study aims to assess the impact of such variant on severe disease from SARS-CoV-2 compared with the Delta variant in Italy. METHODS: Using surveillance data, we assessed the risk of developing severe COVID-19 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrone, Daniele, Mateo-Urdiales, Alberto, Sacco, Chiara, Riccardo, Flavia, Bella, Antonino, Ambrosio, Luigina, Lo Presti, Alessandra, Di Martino, Angela, Ceccarelli, Emiliano, Del Manso, Martina, Fabiani, Massimo, Stefanelli, Paola, Pezzotti, Patrizio, Palamara, AnnaTeresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877142/
https://www.ncbi.nlm.nih.gov/pubmed/36708869
http://dx.doi.org/10.1016/j.ijid.2023.01.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877142/
https://www.ncbi.nlm.nih.gov/pubmed/36708869
http://dx.doi.org/10.1016/j.ijid.2023.01.027

Ejemplares similares